# Rapid Molecular Organism Identification and Mixed Flora Antibiotic Resistance Profiling (MixAR) Prospective Study

> **NCT03931538** · NA · COMPLETED · sponsor: **Pathnostics** · enrollment: 2511 (actual)

## Conditions studied

- Urinary Tract Infections
- Prostatitis
- Interstitial Cystitis

## Interventions

- **DIAGNOSTIC_TEST:** Guidance 4.0 PCR test
- **DIAGNOSTIC_TEST:** Urine Culture

## Key facts

- **NCT ID:** NCT03931538
- **Lead sponsor:** Pathnostics
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-17
- **Primary completion:** 2019-02-22
- **Final completion:** 2019-10-01
- **Target enrollment:** 2511 (ACTUAL)
- **Last updated:** 2023-08-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03931538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03931538, "Rapid Molecular Organism Identification and Mixed Flora Antibiotic Resistance Profiling (MixAR) Prospective Study". Retrieved via AI Analytics 2026-09-11 from https://api.ai-analytics.org/clinical/NCT03931538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*